HPV primary screening incorporating genotyping and p16/Ki-67 dual-stained cytology to determine which HPV positive women would benefit from colposcopy

Wright, Thomas

36
HPV primary screening incorporating genotyping and p16/Ki-67 dual-stained cytology to determine which HPV positive women would benefit from colposcopy

Sunday, March 29, 2015: 5:36 PM

International Ballroom (Hilton Chicago)

T. C. Wright¹, C. M. Behrens², R. Ridder³, A. Sharma² and P. S. Yap²
¹Columbia University College of Physicians and Surgeons, New York, NY, ²Roche Molecular Systems, Pleasanton, CA, ³Ventana Medical Systems, Tucson, AZ

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

36
HPV primary screening incorporating genotyping and p16/Ki-67 dual-stained cytology to determine which HPV positive women would benefit from colposcopy

36 HPV primary screening incorporating genotyping and p16/Ki-67 dual-stained cytology to determine which HPV positive women would benefit from colposcopy

36
HPV primary screening incorporating genotyping and p16/Ki-67 dual-stained cytology to determine which HPV positive women would benefit from colposcopy